Europe Pharma Conferences, The meeting place for pharma professionals from academia, industry, non-profit organization and government bodies to discuss the challenges and successes.

We are bringing together more than 100 elite speakers from Las Vegas, USA, dubai, new york, Chicago, Vancouver, India, UK, san Francisco, Florida, boston, Atlanta, san diego, orlando, Houston, Miami, dallas, san Antonio, phoenix, Edinburgh, Manchester, Birmingham, Melbourne, Brisbane, Canberra, cologne, Toronto, Australia, Germany, Canada, hong kong, florida, Las Vegas, Jordan, Turkey, Spain, UAE, Saudi Arabia, Egypt, Netherlands, France, Italy, Brazil, Israel, China, Japan to inspire and educate our attendees across the globe.

Highly recommended pharma conferences: pharma conferences, pharmaceutical conferences, pharmacy conferences, pharma conferences 2017, international pharmacy conference 2017, PDDS 2017, Pharmaceutics conferences 2017, Pharmaceutics conference 2017, pharma conferences Spain, pharma conferences Valencia, pharma conferences USA, pharma conferences Asia, Pharma conference Europe, pharmaceutical conferences, pharmaceutical conferences 2017

Make sure you are at the forefront of the pharma industry, we have content, networking and potential partners for you at pharma conferences 2017, June 29 - July 1, 2017 at Valencia Spain.

We are bringing together more than 100 elite speakers from Las Vegas, USA, dubai, new york, Chicago, Vancouver, India, UK, san Francisco, Florida, boston, Atlanta, san diego, orlando, Houston, Miami, dallas, san Antonio, phoenix, Edinburgh, Manchester, Birmingham, Melbourne, Brisbane, Canberra, cologne, Toronto, Australia, Germany, Canada, hong kong, florida, Las Vegas, Jordan, Turkey, Spain, UAE, Saudi Arabia, Egypt, Netherlands, France, Italy, Brazil, Israel, China, Japan to inspire and educate our attendees across the globe.

Highly recommended pharma conferences: pharma conferences, pharmaceutical conferences, pharmacy conferences, pharma conferences 2017, international pharmacy conference 2017, PDDS 2017, Pharmaceutics conferences 2017, Pharmaceutics conference 2017, pharma conferences Spain, pharma conferences Valencia, pharma conferences USA, pharma conferences Asia, Pharma conference Europe, pharmaceutical conferences, pharmaceutical conferences 2017

International pharma conferences 2017 will bring the experts from the whole value chain under one roof, which facilitate the plan for future manufacture, research and development.

We are bringing together more than 100 elite speakers from Las Vegas, USA, dubai, new york, Chicago, Vancouver, India, UK, san Francisco, Florida, boston, Atlanta, san diego, orlando, Houston, Miami, dallas, san Antonio, phoenix, Edinburgh, Manchester, Birmingham, Melbourne, Brisbane, Canberra, cologne, Toronto, Australia, Germany, Canada, hong kong, florida, Las Vegas, Jordan, Turkey, Spain, UAE, Saudi Arabia, Egypt, Netherlands, France, Italy, Brazil, Israel, China, Japan to inspire and educate our attendees across the globe.

Highly recommended pharma conferences: pharma conferences, pharmaceutical conferences, pharmacy conferences, pharma conferences 2017, international pharmacy conference 2017, PDDS 2017, Pharmaceutics conferences 2017, Pharmaceutics conference 2017, pharma conferences Spain, pharma conferences Valencia, pharma conferences USA, pharma conferences Asia, Pharma conference Europe, pharmaceutical conferences, pharmaceutical conferences 2017

Pharma conference, this event is dedicated to fostering partnerships and collaboration amongst the pharma professionals from the industry and academia and non-profit organization and government bodies. We are bringing together more than 100 elite speakers from Las Vegas, USA, dubai, new york, Chicago, Vancouver, India, UK, san Francisco, Florida, boston, Atlanta, san diego, orlando, Houston, Miami, dallas, san Antonio, phoenix, Edinburgh, Manchester, Birmingham, Melbourne, Brisbane, Canberra, cologne, Toronto, Australia, Germany, Canada, hong kong, florida, Las Vegas, Jordan, Turkey, Spain, UAE, Saudi Arabia, Egypt, Netherlands, France, Italy, Brazil, Israel, China, Japan to inspire and educate our attendees across the globe.

Highly recommended pharma conferences: pharma conferences, pharmaceutical conferences, pharmacy conferences, pharma conferences 2017, international pharmacy conference 2017, PDDS 2017, Pharmaceutics conferences 2017, Pharmaceutics conference 2017, pharma conferences Spain, pharma conferences Valencia, pharma conferences USA, pharma conferences Asia, Pharma conference Europe, pharmaceutical conferences, pharmaceutical conferences 2017

To discuss scientific and commercial issues around regulation, manufacturing, partnering, trails in the field of pharma, join the leading experts at pharma conferences 2017.

We are bringing together more than 100 elite speakers from Las Vegas, USA, dubai, new york, Chicago, Vancouver, India, UK, san Francisco, Florida, boston, Atlanta, san diego, orlando, Houston, Miami, dallas, san Antonio, phoenix, Edinburgh, Manchester, Birmingham, Melbourne, Brisbane, Canberra, cologne, Toronto, Australia, Germany, Canada, hong kong, florida, Las Vegas, Jordan, Turkey, Spain, UAE, Saudi Arabia, Egypt, Netherlands, France, Italy, Brazil, Israel, China, Japan to inspire and educate our attendees across the globe.

Highly recommended pharma conferences: pharma conferences, pharmaceutical conferences, pharmacy conferences, pharma conferences 2017, international pharmacy conference 2017, PDDS 2017, Pharmaceutics conferences 2017, Pharmaceutics conference 2017, pharma conferences Spain, pharma conferences Valencia, pharma conferences USA, pharma conferences Asia, Pharma conference Europe, pharmaceutical conferences, pharmaceutical conferences 2017

 

Tugba Gungor

Title: The Applications of Potential Aromatic Prodrugs In NTR Based Cancer Therapy

Tugba Gungor

Canakkale Onsekiz Mart University, Turkey

Biography

Dr. Tuğba Güngör graduated as BSc at Chemistry Department of Ankara University in 2007 and graduated as MSc in in 2010 under supervision of Dr. Mustafa GÜLLÜ and PhD in 2016 at Chemistry Department of Çanakkale Onsekiz Mart University under supervision of Dr. Mehmet AY. During the PhD education, worked at Dr. Rich Carter’s Research Lab. at Chemistry Department of Oregon State University at USA for 6 months at 2015. Since 2011, works as a research assistant at Chemistry Department of Çanakkale Onsekiz Mart University and going on research activities in Natural Products and Drug Research Laboratory, focusing on developing new prodrug and drug molecules for Cancer Therapy and other Medicinal Applications.

Abstract

Nitroreductase enzymes catalyze the conversion of the nitro group of prodrug compounds via hydroxylamine to amine group and the active drug inhibits tumor formation by binding to DNA1,2. E. coli NTR/CB1954 (5-aziridinyl-2,4-dinitrobenzamide) is the best known combination that have studied phase I/II trial for different cancer types3. So more effective NTR/drug combination should be investigated for cancer therapies. 

In this study, first of all, we explored and characterized two novel nitroreductases (Ssap-NtrB-cloned from a mesophilic microorganism and Gk-Ntr-cloned from a thermophilic microorganism) with enhanced activity-selectivity and implemented various applications4,5. And nitro group containing two potential prodrugs (isoxazole derivatives and 3,5-difluorophenyl derivatives) were synthesized and were investigated the interaction of these potential pro-drugs with NTR enzymes by spectroscopic techniques and HPLC analysis. Michaelis-Menten kinetic parameters were calculated for reduction reactions of prodrugs and compared common known prodrugs like as CB1954 and SN23862. The prodrugs were evaluated by MTT and SRB assay in three different cancer cell lines, Human Hepatoma Cancer (Hep3B), Human Colon Cancer (HT-29) and Human Prostate Cancer (PC3) in addition to non-cancer cell, HUVEC. According to our results, proposed enzyme/prodrug combinations may use NTR based cancer therapy.

Audience will learn:
•Learn the importance of nitroreductase to drug design and other applications,
•Synthesis of new prodrug candidates,
•Design new projects with collaboration for cancer therapy